AW
BIB icon

Avion Wealth’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Avion Wealth’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-62
Closed -$4K – 518
2022
Q1 		$4K Hold
62
– – ﹤0.01% 301
2021
Q4 		$5K Hold
62
– – ﹤0.01% 285
2021
Q3 		$6K Hold
62
– – ﹤0.01% 265
2021
Q2 		$6K Buy
+62
New +$5.41K ﹤0.01% 250

Other funds holding BIB

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Avion Wealth's BIB Position: Q2 2022 in Review

Avion Wealth sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q2 2022, closing a stake of 62 shares — an estimated $4K sold.

Avion Wealth first reported a position in BIB in Q2 2021 and held it in 4 quarters. The position peaked at $6K in Q3 2021. 24 funds tracked by Wall St. Rank hold BIB as of Q2 2022.

  • Avion Wealth reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q2 2022 after selling out during the quarter.
  • Avion Wealth sold 62 ProShares Ultra NASDAQ Biotechnology shares in Q2 2022, an estimated $4K.
  • Avion Wealth first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2021 and held it in 4 quarters.
  • Avion Wealth's ProShares Ultra NASDAQ Biotechnology position peaked at $6K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2022.

Based on Avion Wealth's 13F filing for Q2 2022, filed 11 Aug 2022.